StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.82+0.03 (+3.89%)

Close on Nov 17, 2026Market cap $94.88MP/E –Yield –

NovaBridge Biosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

NovaBridge Biosciences's profit margin for the twelve months ending Dec 31, 2019 was -4839.8%. For fiscal 2023 it was -5302.0%, against -2648.7% the year before. The highest annual figure on record is 30.5% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023-5302.0%−2653.3
FY2021Dec 31, 2021-2648.7%−2679.2
FY2020Dec 31, 202030.5%+4870.4
FY2019Dec 31, 2019-4839.8%−4090.8
FY2018Dec 31, 2018-749.0%+1831.8
FY2017Dec 31, 2017-2580.8%–

More NovaBridge Biosciences figures

See a number that looks wrong?